Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Relationship between AHI, Oximetric Parameters and Comorbidities in Adult and Elderly Patients with Moderate-to- Severe OSAS: An Observational Study

View through CrossRef
Background: OSAS is a chronic disease characterised by recurrent episodes of apnoea/hypopnoea, which generate chronic intermittent hypoxia, the main etiopathogenetic factor of OSAS-related comorbidities: cerebro-cardiovascular, metabolic and cognitive deficits. Although it represents a major public health problem, it is under-diagnosed. At polygraphy, the Apnoea-Hypopnoea Index (AHI) identifies the number of obstructive episodes, while the oximetry parameters ODI, T90 and minimum and mean SpO2 measure the severity of chronic intermittent hypoxia. Aim of the Study: To test: 1 the usefulness of oximetry parameters in identifying adult and elderly patients with moderate-severe OSAS at higher risk of comorbidities; 2 whether there is a statistically significant association between oximetry parameters and CIRS-G in the elderly; 3 whether CPAP use >4 hours is a protective factor for comorbidities in the elderly. Materials and Methods: A total of 220 patients with moderate-severe OSAS without respiratory comorbidities were enrolled and data on: anthropometric variables, lifestyle, comorbidities and drug therapy were collected. The MMSE and sleep questionnaires (ESS, PSQI, AIS) were administered. The AHI and oximetric parameters were extracted from the polygraph. A value of <30 and ≥30 was chosen as cut-off for ODI, for T90 <20% and ≥20%, for minimum SpO2 <75% and ≥75% and for mean SpO2 <91% and ≥91%. Pcs were divided into two groups of age <65 and ≥65; for the group with age ≥65, the Comorbidity Index (CI) and Severity Index (IS) of the CIRS-G Scale were calculated. In addition, the patients, who accepted CPAP, were followed up at 1-3-6 months, at 1 year and once a year. Results: A high (OR >1) and statistically significant (p<0.05) risk emerged of having diabetes mellitus with ODI ≥30; heart disease with mean SpO2 <91%; hypertension, diabetes mellitus and heart disease with T90 ≥20%. The increased risk for cognitive deficits and heart disease with AHI ≥30 was also statistically significant (p<0.05). Linear regression analysis showed that the T90 >20% -SpO2 minimum <75% interaction is positively associated with CI of the CIRS-G scale (p<0.05) and that CPAP use >4 hours is negatively associated with CI and IS of the CIRS-G scale (p<0.05). Conclusions: In moderate-severe OSAS, oximetry parameters, beyond the AHI, are useful in identifying those adult and elderly patients at higher risk of comorbidities. During the obstructive event, having a minimum SpO2 <75% for a long time (T90 ≥20%) increases CI in the elderly. Increased compliance with CPAP, the gold standard treatment of OSAS, is a protective factor for comorbidities in the elderly.
Title: Relationship between AHI, Oximetric Parameters and Comorbidities in Adult and Elderly Patients with Moderate-to- Severe OSAS: An Observational Study
Description:
Background: OSAS is a chronic disease characterised by recurrent episodes of apnoea/hypopnoea, which generate chronic intermittent hypoxia, the main etiopathogenetic factor of OSAS-related comorbidities: cerebro-cardiovascular, metabolic and cognitive deficits.
Although it represents a major public health problem, it is under-diagnosed.
At polygraphy, the Apnoea-Hypopnoea Index (AHI) identifies the number of obstructive episodes, while the oximetry parameters ODI, T90 and minimum and mean SpO2 measure the severity of chronic intermittent hypoxia.
Aim of the Study: To test: 1 the usefulness of oximetry parameters in identifying adult and elderly patients with moderate-severe OSAS at higher risk of comorbidities; 2 whether there is a statistically significant association between oximetry parameters and CIRS-G in the elderly; 3 whether CPAP use >4 hours is a protective factor for comorbidities in the elderly.
Materials and Methods: A total of 220 patients with moderate-severe OSAS without respiratory comorbidities were enrolled and data on: anthropometric variables, lifestyle, comorbidities and drug therapy were collected.
The MMSE and sleep questionnaires (ESS, PSQI, AIS) were administered.
The AHI and oximetric parameters were extracted from the polygraph.
A value of <30 and ≥30 was chosen as cut-off for ODI, for T90 <20% and ≥20%, for minimum SpO2 <75% and ≥75% and for mean SpO2 <91% and ≥91%.
Pcs were divided into two groups of age <65 and ≥65; for the group with age ≥65, the Comorbidity Index (CI) and Severity Index (IS) of the CIRS-G Scale were calculated.
In addition, the patients, who accepted CPAP, were followed up at 1-3-6 months, at 1 year and once a year.
Results: A high (OR >1) and statistically significant (p<0.
05) risk emerged of having diabetes mellitus with ODI ≥30; heart disease with mean SpO2 <91%; hypertension, diabetes mellitus and heart disease with T90 ≥20%.
The increased risk for cognitive deficits and heart disease with AHI ≥30 was also statistically significant (p<0.
05).
Linear regression analysis showed that the T90 >20% -SpO2 minimum <75% interaction is positively associated with CI of the CIRS-G scale (p<0.
05) and that CPAP use >4 hours is negatively associated with CI and IS of the CIRS-G scale (p<0.
05).
Conclusions: In moderate-severe OSAS, oximetry parameters, beyond the AHI, are useful in identifying those adult and elderly patients at higher risk of comorbidities.
During the obstructive event, having a minimum SpO2 <75% for a long time (T90 ≥20%) increases CI in the elderly.
Increased compliance with CPAP, the gold standard treatment of OSAS, is a protective factor for comorbidities in the elderly.

Related Results

Retinal vascular impairment in patients newly diagnosed with obstructive sleep apnea syndrome
Retinal vascular impairment in patients newly diagnosed with obstructive sleep apnea syndrome
Background: To evaluate retinal morphological and vascular parameters in patients recently diagnosed with obstructive sleep apnea syndrome (OSAS) and determine the correlation betw...
Heart rhythm disorder in patients with obstructive sleep apnoea syndrome
Heart rhythm disorder in patients with obstructive sleep apnoea syndrome
Objective To investigate the risk factors which lead to arrhythmias in patients with obstructive sleep apnoea syndrome (OSAS), to explore incidence and types of a...
The Relationship Between Leptin Levels and CPAP Treatment: A Cluster Analysis
The Relationship Between Leptin Levels and CPAP Treatment: A Cluster Analysis
Abstract Background: Leptin is an appetite-suppressing hormone, released by adipose tissues, that plays an important role in severe obstructive sleep apnea syndrome (OSAS)....
P418 CARDIOMETABOLIC ALTERATIONS IN OBESE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
P418 CARDIOMETABOLIC ALTERATIONS IN OBESE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME
Abstract Background Obesity and Obstructive Sleep Apnea Syndrome (OSAS) has been recognized as two of the major cardiac risk fac...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract Introduction Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top